+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Newswire Kalyagen Announces Registration Of Stemregen In Spain Ceo At Madrid Stem Cell Symposium is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Newswire Kalyagen Announces Registration Of Stemregen In Spain Ceo At Madrid Stem Cell Symposium | RobinsPost News & Noticias

Kalyagen™ Announces Registration of STEMREGEN%C2%AE in Spain, CEO at Madrid Stem Cell Symposium - MENAFN.COM


AUSTIN, Texas, Oct. 12, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce the successful product registration of STEMREGEN® in Spain ... Read More

Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN® and Stem Cells for Advanced Heart Failure Patients - Herald-Mail Media


AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and ... Read More

Kalyagen Announces Next 'The Stemregen Effect' Commercial Featuring Chris Spencer to be Filmed in Belize - KSL News


Kalyagen\u2122 is pleased to announce that the next part of \ Kalyagen Announces Next 'The Stemregen Effect' Commercial Featuring Chris Spencer to be Filmed in Belize | KSL.com Skip to content ... Read More

STEMTECH CORPORATION ANNOUNCES THE INTRODUCTION OF A NEW STEM CELL SKINCARE PRODUCT LINE - Yahoo Finance


MIRAMAR, FL, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today ... Read More

BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health - Morningstar


LAS VEGAS, Dec. 10, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT) is thrilled to announce the launch of Xcellara™ Stem Cell Activator, a groundbreaking supplement that ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus